Zhengye Biotechnology Holding (ZYBT) Enterprise Value (2023 - 2025)
Historic Enterprise Value for Zhengye Biotechnology Holding (ZYBT) over the last 3 years, with Q2 2025 value amounting to $6.6 million.
- Zhengye Biotechnology Holding's Enterprise Value changed N/A to $6.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $6.6 million, marking a year-over-year change of. This contributed to the annual value of $7.0 million for FY2024, which is 2527.12% up from last year.
- Zhengye Biotechnology Holding's Enterprise Value amounted to $6.6 million in Q2 2025.
- Zhengye Biotechnology Holding's Enterprise Value's 5-year high stood at $7.0 million during Q4 2024, with a 5-year trough of $5.4 million in Q4 2023.
- For the 3-year period, Zhengye Biotechnology Holding's Enterprise Value averaged around $6.3 million, with its median value being $6.6 million (2025).
- Within the past 5 years, the most significant YoY rise in Zhengye Biotechnology Holding's Enterprise Value was 2767.14% (2024), while the steepest drop was 2767.14% (2024).
- Quarter analysis of 3 years shows Zhengye Biotechnology Holding's Enterprise Value stood at $5.4 million in 2023, then increased by 27.67% to $7.0 million in 2024, then decreased by 5.49% to $6.6 million in 2025.
- Its Enterprise Value stands at $6.6 million for Q2 2025, versus $7.0 million for Q4 2024 and $5.4 million for Q4 2023.